KeyBanc analyst Paul Knight downgraded Gerresheimer (GRRMF) to Sector Weight from Overweight without a price target The firm thinks the recent ...

Investing.com -- Gerresheimer AG (ETR: GXIG) has been downgraded to “sector weight” from “overweight,” by analysts at KeyBanc Capital Markets following reports of a private equity bid that offers ...

With its stock down 7.1% over the past month, it is easy to disregard Gerresheimer (ETR:GXI). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with ...

A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG , which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a price ...

A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , Bloomberg News reported on Wednesday citing people familiar with the matter.

The potential acquisition comes as Gerresheimer AG, known for producing pens for injectable weight loss drugs like Wegovy, has been in preliminary talks with private equity investors regarding a sale.

A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the ...

FRANKFURT/NEW YORK (Reuters) -A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to inject weight loss drugs like Wegovy ...

A group comprising private equity companies Warburg Pincus and KKR is reportedly in discussions to acquire Gerresheimer, a German company specialising in packaging for medicines and beauty products.